Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US6124304 | NOVARTIS | Penciclovir for the treatment of zoster associated pain |
Oct, 2014
(9 years ago) | |
US5866581 | NOVARTIS | Penciclovir for the treatment of post therapeutic neuralgia |
Oct, 2014
(9 years ago) | |
US6124304 (Pediatric) | NOVARTIS | Penciclovir for the treatment of zoster associated pain |
Apr, 2015
(9 years ago) | |
US5866581 (Pediatric) | NOVARTIS | Penciclovir for the treatment of post therapeutic neuralgia |
Apr, 2015
(9 years ago) | |
US5916893 | NOVARTIS | Treatment of a latent infection of herpes virus |
Sep, 2015
(8 years ago) | |
US5840763 | NOVARTIS | Treatment of a latent infection of herpes viruses |
Sep, 2015
(8 years ago) | |
US5840763 (Pediatric) | NOVARTIS | Treatment of a latent infection of herpes viruses |
Mar, 2016
(8 years ago) | |
US5916893 (Pediatric) | NOVARTIS | Treatment of a latent infection of herpes virus |
Mar, 2016
(8 years ago) |
Drug Exclusivity | Drug Exclusivity Expiration |
---|---|
M(M-54) | Dec 24, 2012 |
M(M-98) | Jan 31, 2014 |
M(M-112) | Feb 09, 2015 |
Pediatric Exclusivity(PED) | Jun 24, 2013 |
Market Authorisation Date: 11 December, 1995
Treatment: Method of treating varicella zoster (shingles) infections
Dosage: TABLET;ORAL